Review



rabbit polyclonal anti-sumo1 antibody fl-101  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Santa Cruz Biotechnology rabbit polyclonal anti-sumo1 antibody fl-101
    Rabbit Polyclonal Anti Sumo1 Antibody Fl 101, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-sumo1 antibody fl-101/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-sumo1 antibody fl-101 - by Bioz Stars, 2026-06
    90/100 stars

    Images



    Similar Products

    90
    Santa Cruz Biotechnology rabbit polyclonal anti-sumo1 antibody fl-101
    Rabbit Polyclonal Anti Sumo1 Antibody Fl 101, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-sumo1 antibody fl-101/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-sumo1 antibody fl-101 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology primary antibody against sumo1 fl-101
    AAV2 capsids are SUMOylated. Shown is an analysis of purified AAV2 particles. To determine AAV2 capsid modification by SUMO, we analyzed AAV2 vectors after purification by iodixanol gradient centrifugation. (a and b) AAV2 capsids and AAV1, -5, -8, and -9 capsids produced in 293T cells and analyzed by <t>anti-SUMO1-specific</t> antibodies or an antibody specific for all three AAV capsid proteins (B1 antibody). (c) Strategy to produce non-SUMOylated (n-s-) AAV2. HEK293T-Gam1 cells were transfected with three plasmids for AAV vector production. Induction of the avian adenovirus CELO Gam1 protein by doxycycline (Dox) leads to inactivation of the Sae1/2 E1 complex, leading to inactivation of the SUMOylation machinery. (d) Western blot analysis of Gam1 protein expression over time after Dox induction using Myc-tag antibody. HeLa-Gam1 cells were induced with 50 ng/ml Dox, and then cell lysate was harvested after 1, 3, 6, 9, 12, and 24 h. (e) Induction of Gam1 leads to higher transduction rates by AAV. HEK293T-Gam1 cells were incubated with and without Dox and then transduced with (SUMOylated) AAV-Luc vectors. RLU, relative light units. (f) Western blot analysis of AAV2 particles produced in 293T-Gam1 cells with (n-s-AAV2) or without Dox induction using SUMO1 and VP-specific antibodies. (g) Immunoprecipitation of AAV capsids. Purified AAV2 capsids were precipitated either with the AAV capsid-specific antibody A20 or with an anti-SUMO1 antibody. Precipitated proteins were then detected with either VP-specific antibody B1 or anti-SUMO1 antibody. As a specificity control, purified human papillomavirus type 58 capsids were precipitated using an unrelated antibody (K18L2).
    Primary Antibody Against Sumo1 Fl 101, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against sumo1 fl-101/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibody against sumo1 fl-101 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology anti-sumo1 (fl-101
    AAV2 capsids are SUMOylated. Shown is an analysis of purified AAV2 particles. To determine AAV2 capsid modification by SUMO, we analyzed AAV2 vectors after purification by iodixanol gradient centrifugation. (a and b) AAV2 capsids and AAV1, -5, -8, and -9 capsids produced in 293T cells and analyzed by <t>anti-SUMO1-specific</t> antibodies or an antibody specific for all three AAV capsid proteins (B1 antibody). (c) Strategy to produce non-SUMOylated (n-s-) AAV2. HEK293T-Gam1 cells were transfected with three plasmids for AAV vector production. Induction of the avian adenovirus CELO Gam1 protein by doxycycline (Dox) leads to inactivation of the Sae1/2 E1 complex, leading to inactivation of the SUMOylation machinery. (d) Western blot analysis of Gam1 protein expression over time after Dox induction using Myc-tag antibody. HeLa-Gam1 cells were induced with 50 ng/ml Dox, and then cell lysate was harvested after 1, 3, 6, 9, 12, and 24 h. (e) Induction of Gam1 leads to higher transduction rates by AAV. HEK293T-Gam1 cells were incubated with and without Dox and then transduced with (SUMOylated) AAV-Luc vectors. RLU, relative light units. (f) Western blot analysis of AAV2 particles produced in 293T-Gam1 cells with (n-s-AAV2) or without Dox induction using SUMO1 and VP-specific antibodies. (g) Immunoprecipitation of AAV capsids. Purified AAV2 capsids were precipitated either with the AAV capsid-specific antibody A20 or with an anti-SUMO1 antibody. Precipitated proteins were then detected with either VP-specific antibody B1 or anti-SUMO1 antibody. As a specificity control, purified human papillomavirus type 58 capsids were precipitated using an unrelated antibody (K18L2).
    Anti Sumo1 (Fl 101, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-sumo1 (fl-101/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-sumo1 (fl-101 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology antibodies to sumo1 (fl-101)
    AAV2 capsids are SUMOylated. Shown is an analysis of purified AAV2 particles. To determine AAV2 capsid modification by SUMO, we analyzed AAV2 vectors after purification by iodixanol gradient centrifugation. (a and b) AAV2 capsids and AAV1, -5, -8, and -9 capsids produced in 293T cells and analyzed by <t>anti-SUMO1-specific</t> antibodies or an antibody specific for all three AAV capsid proteins (B1 antibody). (c) Strategy to produce non-SUMOylated (n-s-) AAV2. HEK293T-Gam1 cells were transfected with three plasmids for AAV vector production. Induction of the avian adenovirus CELO Gam1 protein by doxycycline (Dox) leads to inactivation of the Sae1/2 E1 complex, leading to inactivation of the SUMOylation machinery. (d) Western blot analysis of Gam1 protein expression over time after Dox induction using Myc-tag antibody. HeLa-Gam1 cells were induced with 50 ng/ml Dox, and then cell lysate was harvested after 1, 3, 6, 9, 12, and 24 h. (e) Induction of Gam1 leads to higher transduction rates by AAV. HEK293T-Gam1 cells were incubated with and without Dox and then transduced with (SUMOylated) AAV-Luc vectors. RLU, relative light units. (f) Western blot analysis of AAV2 particles produced in 293T-Gam1 cells with (n-s-AAV2) or without Dox induction using SUMO1 and VP-specific antibodies. (g) Immunoprecipitation of AAV capsids. Purified AAV2 capsids were precipitated either with the AAV capsid-specific antibody A20 or with an anti-SUMO1 antibody. Precipitated proteins were then detected with either VP-specific antibody B1 or anti-SUMO1 antibody. As a specificity control, purified human papillomavirus type 58 capsids were precipitated using an unrelated antibody (K18L2).
    Antibodies To Sumo1 (Fl 101), supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies to sumo1 (fl-101)/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    antibodies to sumo1 (fl-101) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology anti sumo1 fl 101
    AAV2 capsids are SUMOylated. Shown is an analysis of purified AAV2 particles. To determine AAV2 capsid modification by SUMO, we analyzed AAV2 vectors after purification by iodixanol gradient centrifugation. (a and b) AAV2 capsids and AAV1, -5, -8, and -9 capsids produced in 293T cells and analyzed by <t>anti-SUMO1-specific</t> antibodies or an antibody specific for all three AAV capsid proteins (B1 antibody). (c) Strategy to produce non-SUMOylated (n-s-) AAV2. HEK293T-Gam1 cells were transfected with three plasmids for AAV vector production. Induction of the avian adenovirus CELO Gam1 protein by doxycycline (Dox) leads to inactivation of the Sae1/2 E1 complex, leading to inactivation of the SUMOylation machinery. (d) Western blot analysis of Gam1 protein expression over time after Dox induction using Myc-tag antibody. HeLa-Gam1 cells were induced with 50 ng/ml Dox, and then cell lysate was harvested after 1, 3, 6, 9, 12, and 24 h. (e) Induction of Gam1 leads to higher transduction rates by AAV. HEK293T-Gam1 cells were incubated with and without Dox and then transduced with (SUMOylated) AAV-Luc vectors. RLU, relative light units. (f) Western blot analysis of AAV2 particles produced in 293T-Gam1 cells with (n-s-AAV2) or without Dox induction using SUMO1 and VP-specific antibodies. (g) Immunoprecipitation of AAV capsids. Purified AAV2 capsids were precipitated either with the AAV capsid-specific antibody A20 or with an anti-SUMO1 antibody. Precipitated proteins were then detected with either VP-specific antibody B1 or anti-SUMO1 antibody. As a specificity control, purified human papillomavirus type 58 capsids were precipitated using an unrelated antibody (K18L2).
    Anti Sumo1 Fl 101, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti sumo1 fl 101/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    anti sumo1 fl 101 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology sumo1 fl 101
    Antibody information.
    Sumo1 Fl 101, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sumo1 fl 101/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    sumo1 fl 101 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    AAV2 capsids are SUMOylated. Shown is an analysis of purified AAV2 particles. To determine AAV2 capsid modification by SUMO, we analyzed AAV2 vectors after purification by iodixanol gradient centrifugation. (a and b) AAV2 capsids and AAV1, -5, -8, and -9 capsids produced in 293T cells and analyzed by anti-SUMO1-specific antibodies or an antibody specific for all three AAV capsid proteins (B1 antibody). (c) Strategy to produce non-SUMOylated (n-s-) AAV2. HEK293T-Gam1 cells were transfected with three plasmids for AAV vector production. Induction of the avian adenovirus CELO Gam1 protein by doxycycline (Dox) leads to inactivation of the Sae1/2 E1 complex, leading to inactivation of the SUMOylation machinery. (d) Western blot analysis of Gam1 protein expression over time after Dox induction using Myc-tag antibody. HeLa-Gam1 cells were induced with 50 ng/ml Dox, and then cell lysate was harvested after 1, 3, 6, 9, 12, and 24 h. (e) Induction of Gam1 leads to higher transduction rates by AAV. HEK293T-Gam1 cells were incubated with and without Dox and then transduced with (SUMOylated) AAV-Luc vectors. RLU, relative light units. (f) Western blot analysis of AAV2 particles produced in 293T-Gam1 cells with (n-s-AAV2) or without Dox induction using SUMO1 and VP-specific antibodies. (g) Immunoprecipitation of AAV capsids. Purified AAV2 capsids were precipitated either with the AAV capsid-specific antibody A20 or with an anti-SUMO1 antibody. Precipitated proteins were then detected with either VP-specific antibody B1 or anti-SUMO1 antibody. As a specificity control, purified human papillomavirus type 58 capsids were precipitated using an unrelated antibody (K18L2).

    Journal: Journal of Virology

    Article Title: SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms

    doi: 10.1128/JVI.00871-20

    Figure Lengend Snippet: AAV2 capsids are SUMOylated. Shown is an analysis of purified AAV2 particles. To determine AAV2 capsid modification by SUMO, we analyzed AAV2 vectors after purification by iodixanol gradient centrifugation. (a and b) AAV2 capsids and AAV1, -5, -8, and -9 capsids produced in 293T cells and analyzed by anti-SUMO1-specific antibodies or an antibody specific for all three AAV capsid proteins (B1 antibody). (c) Strategy to produce non-SUMOylated (n-s-) AAV2. HEK293T-Gam1 cells were transfected with three plasmids for AAV vector production. Induction of the avian adenovirus CELO Gam1 protein by doxycycline (Dox) leads to inactivation of the Sae1/2 E1 complex, leading to inactivation of the SUMOylation machinery. (d) Western blot analysis of Gam1 protein expression over time after Dox induction using Myc-tag antibody. HeLa-Gam1 cells were induced with 50 ng/ml Dox, and then cell lysate was harvested after 1, 3, 6, 9, 12, and 24 h. (e) Induction of Gam1 leads to higher transduction rates by AAV. HEK293T-Gam1 cells were incubated with and without Dox and then transduced with (SUMOylated) AAV-Luc vectors. RLU, relative light units. (f) Western blot analysis of AAV2 particles produced in 293T-Gam1 cells with (n-s-AAV2) or without Dox induction using SUMO1 and VP-specific antibodies. (g) Immunoprecipitation of AAV capsids. Purified AAV2 capsids were precipitated either with the AAV capsid-specific antibody A20 or with an anti-SUMO1 antibody. Precipitated proteins were then detected with either VP-specific antibody B1 or anti-SUMO1 antibody. As a specificity control, purified human papillomavirus type 58 capsids were precipitated using an unrelated antibody (K18L2).

    Article Snippet: The membrane was blocked in 5% milk PBS-T at RT and then incubated with the desired primary antibody against SUMO1 (1:500; FL-101; Santa Cruz), SUMO2/3 (PA5-11373; 1:1,000; Sigma), DAXX (25c12, 1:1,000; CST), HA (1:500; sc-805; Santa Cruz), α-actin (1:5,000; MP), and VP (1:500 B1; Progen) in 5% PBS-T milk overnight at 4°C.

    Techniques: Purification, Modification, Gradient Centrifugation, Produced, Transfection, Plasmid Preparation, Western Blot, Expressing, Transduction, Incubation, Immunoprecipitation, Control

    VP2 is a target for SUMOylation. (a) AAV2 vectors lacking either VP2, VP1, or VP1/2 were produced and purified by iodixanol gradient centrifugation. Vectors were analyzed by Western blotting using an anti-SUMO1 or the VP-specific antibody B1. (b) Analysis of AAV2 vectors carrying an N-terminally modified VP2. Vectors were produced as described for panel a. Lane 4 shows AAV vectors carrying a VP2 N-terminally fused GFP, and in lane 5 the HA tag is fused to the N terminus of VP2. (c) Detection of VP using a polyclonal antibody.

    Journal: Journal of Virology

    Article Title: SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms

    doi: 10.1128/JVI.00871-20

    Figure Lengend Snippet: VP2 is a target for SUMOylation. (a) AAV2 vectors lacking either VP2, VP1, or VP1/2 were produced and purified by iodixanol gradient centrifugation. Vectors were analyzed by Western blotting using an anti-SUMO1 or the VP-specific antibody B1. (b) Analysis of AAV2 vectors carrying an N-terminally modified VP2. Vectors were produced as described for panel a. Lane 4 shows AAV vectors carrying a VP2 N-terminally fused GFP, and in lane 5 the HA tag is fused to the N terminus of VP2. (c) Detection of VP using a polyclonal antibody.

    Article Snippet: The membrane was blocked in 5% milk PBS-T at RT and then incubated with the desired primary antibody against SUMO1 (1:500; FL-101; Santa Cruz), SUMO2/3 (PA5-11373; 1:1,000; Sigma), DAXX (25c12, 1:1,000; CST), HA (1:500; sc-805; Santa Cruz), α-actin (1:5,000; MP), and VP (1:500 B1; Progen) in 5% PBS-T milk overnight at 4°C.

    Techniques: Produced, Purification, Gradient Centrifugation, Western Blot, Modification

    Lysine residues located in the N terminus of VP2 are essential for SUMOylation. (a) Sequence of VP with the positions of the lysine-arginine exchanges highlighted. (b) Analysis of iodixanol gradient-purified lysine AAV2 capsid exchange mutants by Western blotting using a SUMO1-specific antibody or the anti-VP specific antibody B1. (Top) K to R exchanges. (Bottom) K to Q exchanges for selected lysines.

    Journal: Journal of Virology

    Article Title: SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms

    doi: 10.1128/JVI.00871-20

    Figure Lengend Snippet: Lysine residues located in the N terminus of VP2 are essential for SUMOylation. (a) Sequence of VP with the positions of the lysine-arginine exchanges highlighted. (b) Analysis of iodixanol gradient-purified lysine AAV2 capsid exchange mutants by Western blotting using a SUMO1-specific antibody or the anti-VP specific antibody B1. (Top) K to R exchanges. (Bottom) K to Q exchanges for selected lysines.

    Article Snippet: The membrane was blocked in 5% milk PBS-T at RT and then incubated with the desired primary antibody against SUMO1 (1:500; FL-101; Santa Cruz), SUMO2/3 (PA5-11373; 1:1,000; Sigma), DAXX (25c12, 1:1,000; CST), HA (1:500; sc-805; Santa Cruz), α-actin (1:5,000; MP), and VP (1:500 B1; Progen) in 5% PBS-T milk overnight at 4°C.

    Techniques: Sequencing, Purification, Western Blot

    AAV2 K105R and K105Q capsid variants are SUMOylated. (a) Analysis of wt and mutant AAV capsid by Western blotting using a SUMO1- or VP-specific antibody. (b) Transduction of HeLa cells with wt and mutant AAV vectors. The y axis indicates relative light units. (c) Effect of SUMOylation knockdown on transduction efficiency of wt and mutant vectors.

    Journal: Journal of Virology

    Article Title: SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms

    doi: 10.1128/JVI.00871-20

    Figure Lengend Snippet: AAV2 K105R and K105Q capsid variants are SUMOylated. (a) Analysis of wt and mutant AAV capsid by Western blotting using a SUMO1- or VP-specific antibody. (b) Transduction of HeLa cells with wt and mutant AAV vectors. The y axis indicates relative light units. (c) Effect of SUMOylation knockdown on transduction efficiency of wt and mutant vectors.

    Article Snippet: The membrane was blocked in 5% milk PBS-T at RT and then incubated with the desired primary antibody against SUMO1 (1:500; FL-101; Santa Cruz), SUMO2/3 (PA5-11373; 1:1,000; Sigma), DAXX (25c12, 1:1,000; CST), HA (1:500; sc-805; Santa Cruz), α-actin (1:5,000; MP), and VP (1:500 B1; Progen) in 5% PBS-T milk overnight at 4°C.

    Techniques: Mutagenesis, Western Blot, Transduction, Knockdown

    Antibody information.

    Journal: Journal of Biomedicine and Biotechnology

    Article Title: Possible Linkage of SP6 Transcriptional Activity with Amelogenesis by Protein Stabilization

    doi: 10.1155/2011/320987

    Figure Lengend Snippet: Antibody information.

    Article Snippet: Sumo1 (FL-101) , Santa Cruz biotechnology , sc-9060 , 1 : 1000 , —.

    Techniques: Ubiquitin Proteomics